EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The effects of artificial sweeteners on body weight, body fat, and energy intake: A meta-analysis of meta-analyses

Fatemeh Hamedi-Kalajahi, Sanaz Asemani, Kousalya Prabahar, Neda Jourabchi-Ghadim, Alireza Ostadrahimi

BioSocial Health journal · 2024-07-04 · 1 (2) · 74-83

DOI: 10.34172/bshj.22 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Overweight and obesity are prevalent worldwide and hence it can be considered as a global epidemic. Artificial sweeteners (ASs) are suggested to decrease energy intake and prevent obesity, however, the results of meta-analyses are inconsistent. Therefore, this umbrella meta-analyses was conducted to resolve these discrepancies and offer definitive evidence on the impact of ASs on body weight (BW), body mass index (BMI), and energy intake. Methods: PubMed, Scopus, EMBASE, and Web of Science were systematically searched from inception up to March 2023. Meta-analyses studies investigating the effect/association of AS on/with BW, BMI, and energy intake were included. Random-effects model was used for performing a meta-analysis. Subgroup analyses were carried out based on various independent variables. The quality of the included meta-analyses was evaluated using the AMSTAR2 questionnaire. Results: In this umbrella review, 12 meta-analyses were included. The findings from the umbrella meta-analysis of interventional studies showed that AS consumption significantly reduced BW according to standardized mean difference (SMD) analysis (ES=-0.38; 95% CI: -0.56, -0.20, P≤0.001), but not when using the weighted mean difference (WMD) (ES=-0.45; 95% CI: -1.15, 0.24, P=0.20). Also, AS did not affect the energy intake (ES=-0.28; 95% CI: -1.15, 0.59, P=0.59) based on WMD. However, AS significantly reduced BMI (ES=-0.28; 95% CI: -0.40, -0.15, P≤0.001) based on WMD analysis. Conversely, the umbrella meta-analysis of observational studies found that consuming ASs was associated with a 61% augmented risk of obesity and overweight. (ES=1.61; 95% CI: 1.36,1.87, P≤0.001). Conclusion: Despite observational studies, interventional studies show the benefits of ASs consumption. Future studies should be conducted focusing on the dose, types, and formulations of ASs, and more importantly, short-term and long-term consumption of ASs.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →